n,n-dimethylarginine has been researched along with Amentia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diakowska, D; Fleszar, MG; Gamian, A; Krzystek-Korpacka, M; Wiśniewski, J; Zboch, M | 1 |
| Asif, M; Mangoni, AA; McEvoy, M; Soiza, RL | 1 |
1 review(s) available for n,n-dimethylarginine and Amentia
| Article | Year |
|---|---|
Asymmetric dimethylarginine: a possible link between vascular disease and dementia.
Topics: Arginine; Brain; Dementia; Endothelium; Enzyme Inhibitors; Humans; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Risk Factors; Vascular Diseases | 2013 |
1 other study(ies) available for n,n-dimethylarginine and Amentia
| Article | Year |
|---|---|
Targeted metabolomic analysis of nitric oxide/L-arginine pathway metabolites in dementia: association with pathology, severity, and structural brain changes.
Topics: Arginine; Biomarkers; Brain; Citrulline; Dementia; Female; Humans; Male; Metabolomics; Middle Aged; Nitric Oxide; Signal Transduction | 2019 |